Sort
51,593 grants matching “hepatitis”
The PRIORITY Study: from PRedIctiOn to pReventIon of youth-onset TYpe 2 diabetes
$758,056Sheela Natesh Magge · Johns Hopkins University · U01 · FY2024 · DK
Effects of aging on primary and secondary vaccine responses in a 15-year longitudinal cohort
$758,055Scott Dexter Boyd · Stanford University · R01 · FY2017 · AI
Generating Exogenic Organs for Transplantation without the Use of Immunosuppression
$758,037Clifford J. Steer · University Of Minnesota · R01 · FY2023 · AI
Mid Southern Primary Care Networks Node
$757,947Li-Tzy T Wu · Duke University · UG1 · FY2017 · DA
The combinatorial effects of Opiates and the emerging promoter-variant strains of HIV-1 subtype C on HIV neuropathogensis and latency
$757,800Shilpa J Buch · University Of Nebraska Medical Center · R01 · FY2019 · DA
HT Image Assay of Lipid Droplet Formation in Human Adipocytes
$757,726Patrick M McDonough · Vala Sciences, Inc. · R44 · FY2008 · DK
Glycemic Load and Resistance Training on Endothelial Function and Inflammation
$757,541Christian K Roberts · University Of California Los Angeles · R01 · FY2011 · DK
Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance use
$757,364Amy Caroline Justice · Yale University · U24 · FY2012 · AA
Acute Hepatitis C Infection in Young Injectors
$757,294Kimberly Page · University Of California, San Francisco · R01 · FY2013 · DA
The effects of orange juice compared with sugar-sweetened beverage on risk factors and metabolic processes associated with the development of cardiovascular disease and type 2 diabetes
$757,234Kimber Lee Stanhope · University Of California At Davis · R01 · FY2018 · HL
HCV Genomic Variability in HIV Infected Hemophiliacs
$756,918University Of Cincinnati · R01 · FY2001 · AI
Childhood Liver Disease Research Network Data Coordinating Center
$756,829John C Magee · University Of Michigan At Ann Arbor · U24 · FY2020 · DK
Development of a hamster model for hepatitis B virus infection
$756,589Zhongde Wang · Utah State University · R01 · FY2024 · AI
Large Scale Synthesis of the Next Generation Synthetic Saponin Adjuvant TiterQuil
$756,567Philip O. Livingston · Adjuvance Technologies, Inc. · R44 · FY2017 · AI
Identification and Characterization of Entry Factors Critical for Rift Valley Fever Virus Infection and Pathogenesis
$756,494Gaya K. Amarasinghe · Washington University · R01 · FY2021 · AI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$756,158James L. Sorensen · University Of California, San Francisco · UG1 · FY2015 · DA
Protein Biomarkers for CVD Prediction in HIV-Infected and Uninfected Veterans
$756,117Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2016 · HL
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$756,106Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2018 · DA
Kinetic and structural basis for SARS-CoV-2 RNA-dependent RNA polymerase specificity and inhibition
$755,988Kenneth Allen Johnson · University Of Texas At Austin · R01 · FY2025 · AI
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
$755,528Marc R Montminy · Salk Institute For Biological Studies · R37 · FY2014 · DK
Blocking a novel cytokine signaling pathway for the treatment of rheumatoid arthr
$755,418Kirill Ostanin · Navigen, Inc. · R44 · FY2015 · AR
HEPATITIS C VIRUS REPLICATION AND LIVER INJURY
$755,272University Of Washington · U19 · FY2001 · AI
The circadian rhythm as a lentiviral vector restriction factor
$755,206Tal Kafri · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HL
Miami Treatment and Prevention Clinical Trials Unit (CTU)
$755,151Margaret A Fischl · University Of Miami School Of Medicine · UM1 · FY2016 · AI
TOPMed Omics of Type 2 Diabetes and Quantitative Traits
$755,009James B Meigs · Massachusetts General Hospital · UM1 · FY2022 · DK